Winter weather set to make a comeback in Swiss mountains thelocal.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelocal.ch Daily Mail and Mail on Sunday newspapers.
INTEGRA Biosciences continues strong growth in 2020
INTEGRA Biosciences AG – based in Zizers, Switzerland and Hudson, New Hampshire – has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes. This is the tenth straight year of sales growth for this hidden champion from the Chur Rhine Valley.
Image Credit: INTEGRA Biosciences
Reporting sales of 130 million Swiss francs in 2020, it has been the best year ever for INTEGRA Biosciences AG. The 73% increase from 2019 was driven by huge demand worldwide for the laboratory instruments it develops and manufactures in Zizers. The company saw particular growth in the sales of pipettes and pipette tips that are being used in diagnostics and research to combat COVID-19. “We are pleased with this excellent performance, and proud of our work contributing towards overcoming the pandemic,” said Urs Hartmann, who has led INTEGRA Biosciences as its CEO
Mar 06 2021 Read 2003 Times
Integra Biosciences AG has released its 2020 annual report, with sales rising 73% compared to the previous year for this manufacturer of laboratory equipment and pipettes. This is the tenth straight year of sales growth for this hidden champion from the Chur Rhine Valley.
Reporting sales of CHF130 in 2020, it has been the best year ever for Integra Biosciences AG. The 73% increase from 2019 was driven by huge demand worldwide for the laboratory instruments it develops and manufactures in Zizers. The company saw particular growth in the sales of pipettes and pipette tips that are being used in diagnostics and research to combat COVID-19. “We are pleased with this excellent performance, and proud of our work contributing towards overcoming the pandemic,” said Urs Hartmann, who has led Integra Biosciences as its CEO since January 2020. Sales have risen consistently since 2010, at a mean annual rate of 23%, and the company won an average of five